Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Follow facility SOPs for multidose vial handling
Licensing deals now feature outcomes-based milestones tied to Phase 2 efficacy targets, reflecting a heightened emphasis on translational proof versus early-stage promise
But be realistic about expectations: these produce modest effects, not prescription-grade results
In individuals with type 2 diabetes, another phase 2 clinical study demonstrated that after 12 weeks of efinopegdutide treatment, although no significant improvement in glycated hemoglobin (HbA1c) levels was observed, the effect on weight loss reached a high of 7.9%, well above the 0.7% weight reduction rate in the placebo group
Lerner, K
US$ 25.39
US$ 24.27
US$ 21.07
US$ 20.01
